Pharsight

Patent	Proceeding Filing Date	Status	Respondent	Petitioner

US10561808	October, 2018	Decision	Declan Walsh et al.

Drug Patent Number	Company	Drug Patent Title	Drug Patent Expiry
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7105152	TEVA BRANDED PHARM	Suspension aerosol formulations	Sep, 2023 (16 days ago)
US8132712	TEVA BRANDED PHARM	Metered-dose inhaler	Sep, 2028 (4 years from now)
US9808587	TEVA BRANDED PHARM	Dose counter for inhaler having an anti-reverse rotation actuator	May, 2031 (7 years from now)
US10086156	TEVA BRANDED PHARM	Dose counter for inhaler and method for counting doses	May, 2031 (7 years from now)
US10022510	TEVA BRANDED PHARM	Dose counters for inhalers, inhalers and methods of assembly thereof	May, 2031 (7 years from now)
US11395889	TEVA BRANDED PHARM	Dose counter for inhaler having an anti-reverse rotation actuator	May, 2031 (7 years from now)
US10022509	TEVA BRANDED PHARM	Dose counter for inhaler having a bore and shaft arrangement	May, 2031 (7 years from now)
US10695512	TEVA BRANDED PHARM	Dose counter for inhaler having an anti-reverse rotation actuator	May, 2031 (7 years from now)
US9463289	TEVA BRANDED PHARM	Dose counters for inhalers, inhalers and methods of assembly thereof	May, 2031 (7 years from now)
US10561808	TEVA BRANDED PHARM	Dose counter for inhaler having an anti-reverse rotation actuator	Jan, 2032 (8 years from now)